Potential anti-TNF response biomarker identified

DNA methylation the next step forward in RA treatment stratification

2014-06-12

(Press-News.org) DNA methylation has been identified as a potential biomarker of response to etanercept and adalimumab in patients with rheumatoid arthritis (RA) according to preliminary results from one of the largest methylome-wide investigations of treatment response to anti-TNF therapies.1 These data, presented today at the European League Against Rheumatism Annual Congress (EULAR 2014), bring clinicians a step closer to being able to personalise a patient's treatment pathway.

Anti-TNF therapies have proved a huge advance for the treatment of rheumatoid arthritis and have transformed the treatment of inflammatory arthritis for millions of people around the world. However, only 20-40% of patients achieve a good response according to EULAR criteria.2

"It can take several years to identify the most effective treatment for an RA patient. This is not only costly in terms of the financial burden, but also in terms of patient outcomes and the irreversible joint damage that is being done," said Amy Webster, University of Manchester, United Kingdom. "Because of this, the identification of biomarkers that can predict a patient's response to a treatment is an important area of research which will allow the most effective treatment for each patient to be identified early in the course of the disease." She continued, "Based on recent studies showing a role for epigenetics in RA and other autoimmune disorders, we hypothesised that epigenetic changes, such as DNA methylation, may provide potential biomarkers of response to anti-TNFs."

RA is a chronic systemic disease that affects the joints, connective tissues, muscle, tendons, and fibrous tissue. A disabling condition that often causes pain and deformity, symptoms of RA tend to appear between the ages of 20 and 40. The prevalence of RA globally varies between 0.3% and 1% and is more common in women and in developed countries. Within 10 years of onset, at least 50% of patients in developed countries are unable to maintain a full-time job.3 1In this study, patients were selected from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS) longitudinal cohort based on having an extreme response phenotype after three months of treatment with etanercept or adalimumab. Of the patients in the study, 36 patients were good responders to etanercept and 45 to adalimumab as defined by having an endpoint of DAS28 0.01 were removed. Differentially methylated positions between responders and non-responders were identified using the F-test following quantile normalisation. In the etanercept study, four CpG* sites showed differential DNA methylation that passed a false discovery rate of 0.05, while in the adalimumab study less significant results were observed. The most differentially methylated position in etanercept patients mapped to the LRPAP1 gene (p=1.46x10-8). This gene encodes a chaperone of low density lipoprotein receptor-related protein 1 (LRP1) which is known to influence TGF-β activity. Technical validation of methylation at this site by pyrosequencing showed very good correlation (Spearmans r=0.8). In the adalimumab patients, the most differentially methylated position maps to the PDZD8 gene. Joint analysis of the two drugs together identified a differentially methylated region overlapping the CRYZ and TYW3 genes, which have previously been associated with inflammation and Type 2 diabetes.4

INFORMATION: Abstract Number: OP0257

NOTES TO EDITORS: For further information on this study, or to request an interview with the study lead, please contact us via: EULAR congress Press Office: Room 104, Palais des congrès de Paris Email: eularpressoffice@cohnwolfe.com Onsite tel: +44 (0) 7880 173209 Twitter: @EULAR_Press

About EULAR The European League Against Rheumatism (EULAR) is an umbrella organisation which represents scientific societies, health professional associations and organisations for people with rheumatic diseases throughout Europe.

EULAR aims to promote, stimulate and support the research, prevention, and treatment of rheumatic diseases and the rehabilitation of those it affects. 1With 45 scientific member societies, 35 People with Arthritis and Rheumatism in Europe (PARE) organisations, 17 health professionals associations and 26 corporate members, EULAR highlights the importance of combating rheumatic diseases through both medical means and patient care.

EULAR 2014 is set to be the biggest rheumatology event in Europe with almost 14,000 scientists, physicians, allied health professionals and related audiences in attendance from 130 countries. Over the course of the congress there will be 302 oral and 1,806 poster abstract presentations, 155 sessions, 725 lectures, 33 poster tours with 421 invited speakers. To find out more about the activities of EULAR, visit: http://www.eular.org

1 Webster A, Plant D, Eyre S et al. Differential DNA methylation related to response to adalimumab and etanercept in patients with rheumatoid arthritis. EULAR 2014; Paris: Abstract OP0257 2 Hetland ML, Christensen J, Tarp U et al. Direct Comparison of Treatment Responses, Remission Rates, and Drug Adherence in Patients With Rheumatoid Arthritis Treated With Adalimumab, Etanercept, or Infliximab. Arthritis Rheum 2010; 62(1): 22󈞌 3 Chronic diseases and Health Promotion: Chronic Rheumatic Conditions, World Health Organisation. http://www.who.int/chp/topics/rheumatic/en/. [Accessed 06/06/2014] 4 Qi Q, Menzaghi C, Smith S et al. Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels. Hum Mol Genet 2012; 21(21):4774-80

* CpG sites – regions of DNA where a cytosine nucleotide occurs next to a guanine nucleotide in the linear sequence of bases along its length

ELSE PRESS RELEASES FROM THIS DATE:

Regular exercise beneficial in suppressing inflammation in rheumatic disease

2014-06-12

Research findings presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) suggest that exercise transiently suppresses local and systemic inflammation, reinforcing the beneficial effects of exercise and the need for this to be regular in order to achieve clinical efficacy in rheumatic disease. Chronic inflammation, swelling and pain in the joints characterise the more than 200 rheumatic diseases. Persistent inflammation over time can damage affected joints, but previous research has established that exercise can decrease joint inflammation ...

Cranial ultrasound may replace temporal artery biopsy in diagnosis of giant cell arteritis

2014-06-12

A new study presented for the first time today at the European League Against Rheumatism Annual Congress (EULAR 2014), shows that cranial ultrasound has a greater sensitivity than temporal artery biopsy,* and a comparable specificity in the diagnosis of Giant Cell Arteritis (GCA).1 Giant Cell Arteritis (GCA), a condition in which medium and large arteries mainly in the head and neck, become inflamed and narrowed, can cause blindness due to occlusion of the artery supplying the back of the eye. It is therefore essential that a prompt, accurate diagnosis of GCA is made ...

New study sheds light on what happens to 'cool' kids

2014-06-12

Teens who tried to act cool in early adolescence were more likely than their peers who didn't act cool to experience a range of problems in early adulthood, according to a new decade-long study. The study, by researchers at the University of Virginia, appears in the journal Child Development. While cool teens are often idolized in popular media—in depictions ranging from James Dean's Rebel Without a Cause to Tina Fey's Mean Girls—seeking popularity and attention by trying to act older than one's age may not yield the expected benefits, according to the study. Researchers ...

Toddlers whose parents use subsidies to buy center-based care more likely to enroll in Head Start

2014-06-12

Children of parents who use subsidies to purchase center-based care in the toddler years are more likely to be enrolled in Head Start or public prekindergarten in their preschool years, according to a new study. The research, conducted at Georgetown University and Columbia University, appears in the journal Child Development. The federally funded child care subsidy program—the Child Care and Development Fund (CCDF)—serves nearly 2 million children a month and is one of the government's biggest investments in the early care and education of low-income children. While the ...

Cancer drug boosts levels of vascular-protective gene, KLF2

2014-06-12

Case Western Reserve University researchers have discovered that an existing drug used to help cancer patients has the potential to protect thousands of others from the often-deadly impact of vascular clots. In 2008, the Food and Drug Administration approved bortezomib (Velcade) to treat multiple myeloma, which is a type of bone cancer and mantle cell lymphoma — a particularly aggressive form of non-Hodgkin lymphoma. In addition to attacking cancer cells, the drug has been shown to help prevent clot development common to many forms of the disease. As hematologist Lalitha ...

Childhood cancer survivors hospitalized frequently years after cancer treatment

2014-06-12

PHILADELPHIA — Survivors of childhood cancers were hospitalized more often and for longer durations because of blood disorders and other problems, many years after cancer treatment was completed, compared with the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "Our findings demonstrate that childhood cancer survivors face ongoing problems that can lead to hospitalization, even for those who are decades past their original cancer diagnosis. This can negatively ...

6,000 steps a day keeps knee OA limitations away

2014-06-12

A new study shows that walking reduces risk of functional limitation associated with knee osteoarthritis (OA). In fact, the study funded in part by grants from the National Institutes of Health (NIH) and published in the American College of Rheumatology (ACR) journal, Arthritis Care & Research, suggests that walking 6,000 or more steps per day may protect those with or at risk of knee of OA from developing mobility issues, such as difficulty getting up from a chair and climbing stairs. Nearly 27 million Americans age 25 and older are diagnosed with OA according to a ...

Low cholesterol linked with worse survival in patients with kidney cancer

2014-06-12

People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease. The findings, which are published in BJU International, indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer. Increasing evidence suggests that alterations in cholesterol and other lipids are associated with the development, progression, and prognosis of various cancers. To assess the situation as it relates to kidney cancer, ...

Scientists weed out pesky poison ivy with discovery of killer fungus

2014-06-12

Much to the chagrin of gardeners, hikers, and virtually anyone enjoying the outdoors, one of the hazards of summer is picking up an itchy poison ivy rash. But researchers in the Virginia Tech College of Agriculture and Life Sciences have found a natural and effective way to kill poison ivy using a naturally occurring fungus that grows on the fleshy tissue surrounding the plant's seed, potentially giving homeowners and forest managers the ability to rid landscapes of the pernicious pest. Their findings could make the maddening itch of the summer season a thing of the ...

Content kingmaker -- quality or webpage position?

2014-06-12

In today's Information Age, it's easy get overwhelmed by online content. On YouTube alone, over 100 hours worth of video is uploaded every minute. Showcasing the most interesting content allows providers to convey a certain level of quality to its audiences and encourages users to stay on the website, consuming content and winning advertising dollars for its provider. However, this influx of information makes it difficult for both content providers and users to determine what is interesting and worth consuming. Due to the sheer volume of submitted content, some providers ...

Potential anti-TNF response biomarker identified

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: